Study of V117957 in Overactive Bladder Syndrome
Condition:   Overactive Bladder Syndrome Interventions:   Drug: V117957;   Drug: Placebo Sponsors:   Imbrium Therapeutics;   Purdue Pharma LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
Conditions:   Overactive Bladder;   Overactive Bladder Syndrome Interventions:   Drug: Oral Solifenacin 5mg;   Device: Transcutaneous Posterior Tibial Nerve Stimulation (TTNS) Sponsor:   Ege University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials